The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China
Authors
Keywords
advanced non-small cell lung cancer (NSCLC), multiple treatments, taxane, nanoparticle albumin bound paclitaxel (Nab-PTX), secreted protein acidic and rich in cysteine (SPARC)
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started